Eric D. Donnenfeld, MD, FAAO, FACS

Founding partner of Ophthalmic Consultants of Long Island and Connecticut, Rockville Centre NY and Fairfield, CT. He is also associate professor of ophthalmology, New York University Medical Center. Co-director of the Cornea Department at Nassau Universit

Articles by Eric D. Donnenfeld, MD, FAAO, FACS

50 years of ophthalmology: What changed the game (Part 2)

BySheryl Stevenson,Eric D. Donnenfeld, MD, FAAO, FACS,Jai G. Parekh, MD, MBA, FAAO,Eva Kim, MD,Joaquin De Rojas, MD

July 9th 2025

Ophthalmologists discuss the most impactful advancements reshaping patient care over five decades.

New ketorolac solution optimized for safety and patient comfort

ByEric D. Donnenfeld, MD, FAAO, FACS,L. David Waterbury, PhD

November 1st 2004

From a patient's perspective, using a non-steroidal anti-inflammatory drug (NSAID) before and after cataract or refractive surgery can help to ease pain, swelling, and irritation, and accelerate the return of visual acuity. From a surgeon's perspective, using an NSAID reduces surgical complications and makes surgery easier: it keeps the pupils larger, allowing for quicker and less traumatic procedures. It also prevents cystoid macular edema (CME) and reduces the incidence of striae because it suppresses pain and, therefore, the patient's tendency to squeeze/rub the eyes post-surgery. This article will examine the different classes of NSAIDs, compare their analgesic and anti-inflammatory activity, and determine the potency of different NSAIDs.